NutriBand Inc. (NTRB) stock
NTRBNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends January 31
Financials through Q2 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 4, 2026Score 4/30225% above fair value
$5.59−0.22 (-3.79%)
Close on Nov 17, 2026Market cap $67.95MP/E –Yield –
NutriBand revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
NutriBand's revenue for the twelve months ending Jul 31, 2026 was $1.62M, down 37.3% year over year. For fiscal 2026 it was $2.04M, down 4.8% from the year before. The highest annual figure on record is $2.14M in fiscal 2025.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | $2.04M | -4.8% |
| FY2025 | Jan 31, 2025 | $2.14M | +2.6% |
| FY2024 | Jan 31, 2024 | $2.09M | +0.3% |
| FY2023 | Jan 31, 2023 | $2.08M | +46.2% |
| FY2022 | Jan 31, 2022 | $1.42M | +50.7% |
| FY2021 | Jan 31, 2021 | $943.70K | +690.6% |
| FY2020 | Jan 31, 2020 | $119.36K | -51.3% |
| FY2019 | Jan 31, 2019 | $245.29K | – |
Quarterly revenue
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2027CQ2 2026 | Jul 31, 2026 | $437.51K | -29.7% |
| Q1 FY2027CQ1 2026 | Apr 30, 2026 | $433.40K | -35.1% |
| Q4 FY2026CQ4 2025 | Jan 31, 2026 | $400.71K | -37.6% |
| Q3 FY2026CQ3 2025 | Oct 31, 2025 | $346.06K | -46.4% |
| Q2 FY2026CQ2 2025 | Jul 31, 2025 | $622.45K | +40.6% |
| Q1 FY2026CQ1 2025 | Apr 30, 2025 | $667.43K | +63.4% |
| Q4 FY2025CQ4 2024 | Jan 31, 2025 | $642.38K | +22.4% |
| Q3 FY2025CQ3 2024 | Oct 31, 2024 | $645.80K | +50.9% |
| Q2 FY2025CQ2 2024 | Jul 31, 2024 | $442.83K | -32.5% |
| Q1 FY2025CQ1 2024 | Apr 30, 2024 | $408.53K | -14.3% |
| Q4 FY2024CQ4 2023 | Jan 31, 2024 | $524.61K | -0.6% |
| Q3 FY2024CQ3 2023 | Oct 31, 2023 | $427.84K | -30.8% |
| Q2 FY2024CQ2 2023 | Jul 31, 2023 | $655.93K | +43.8% |
| Q1 FY2024CQ1 2023 | Apr 30, 2023 | $476.93K | -0.2% |
| Q4 FY2023CQ4 2022 | Jan 31, 2023 | $527.54K | +7.2% |
| Q3 FY2023CQ3 2022 | Oct 31, 2022 | $618.00K | +42.6% |
| Q2 FY2023CQ2 2022 | Jul 31, 2022 | $456.15K | +31.0% |
| Q1 FY2023CQ1 2022 | Apr 30, 2022 | $477.92K | +22.0% |
| Q4 FY2022CQ4 2021 | Jan 31, 2022 | $491.89K | +482.5% |
| Q1 FY2022CQ1 2021 | Apr 30, 2021 | $433.49K | +263.2% |
| Q4 FY2021CQ4 2020 | Jan 31, 2021 | $348.09K | +1678.1% |
| Q3 FY2021CQ3 2020 | Oct 31, 2020 | $391.80K | +374.5% |
| Q2 FY2021CQ2 2020 | Jul 31, 2020 | $84.45K | +12.7% |
| Q1 FY2021CQ1 2020 | Apr 30, 2020 | $119.36K | -38.3% |
| Q4 FY2020CQ4 2019 | Jan 31, 2020 | $19.58K | -76.3% |
| Q3 FY2020CQ3 2019 | Oct 31, 2019 | $82.57K | -49.3% |
| Q2 FY2020CQ2 2019 | Jul 31, 2019 | $74.91K | – |
| Q1 FY2020CQ1 2019 | Apr 30, 2019 | $193.59K | – |
| Q4 FY2019CQ4 2018 | Jan 31, 2019 | $82.47K | – |
| Q3 FY2019CQ3 2018 | Oct 31, 2018 | $162.82K | – |
See a number that looks wrong?